Novo-Nordisk (NVO)
Add to Watchlists Create an Alert
168.64
-0.28 -0.17%
NYSE
May 24, 8:00PM
BATS Real time
Currency in USD
Novo-Nordisk News
Should These Drug Companies Continue to Pay a Dividend?
Fool May 24Should These Drug Companies Continue to Pay a Dividend?
Natixis Upgrades Novo Nordisk (NVO) to Buy
Street Insider May 24The Coming Diabetes Wars
Fool May 23A major battle looms as leading insulin products lose patent protection. Here are the likely winners and losers of the coming diabetes wars.
Positive Data on Novo Nordisk's N9-GP - Analyst Blog
Zacks May 21Novo Nordisk recently announced positive phase III data on its hemophilia B candidate, N9-GP, from the paradigm 2 study.
A New Drug Sales Model
May 20Novo Nordisk (NVO) Reports Positive Results from Paradigm 2
Street Insider May 17Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NVO | 168.64 | -0.28 | -0.17% | 92.75B |
New watchlist
